Chromosomal microarray analysis (CMA) is having an increasingly important role in prenatal testing and may be used as a primary screening tool. In this webinar, our panel of clinical experts discuss the efficiency of CMA in providing more clinically relevant genetic data compared with conventional karyotyping especially with the presence of ultrasound detected fetal anomaly.

Topic: Overview of Chromosomal Microarray Analysis (CMA) in prenatal screening